Russell Ryan, M.D., an assistant professor in the Department of Pathology at the University of Michigan Medical School, and his team, while studying B-cell lymphomas, decided to look at an often overlooked dataset and made a potentially game-changing discovery. Using a method called ChIP-Seq to map the regulatory elements that control gene expression, they found “junk” sequences in a specific type of B-cell lymphoma. Ryan discusses the team’s findings and what it means for treatment.
